Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Histone Deacetylase Inhibitors from Burkholderia thailandensis
  2. Klausmeyer, P.; Shipley, S. M.; Zuck, K. M.; McCloud, T. G.
  3. Journal of Natural Products. 2011, Oct; 74(10): 2039-2044.
  1. 2.   Impact of ABCB1 Allelic Variants on QTc Interval Prolongation
  2. Sissung, T. M.; Gardner, E. R.; Piekarz, R. L.; Howden, R.; Chen, X. H.; Woo, S.; Franke, R.; Clark, J. A.; Miller-DeGraff, L.; Steinberg, S. M.; Venzon, D.; Liewehr, D.; Kleeberger, S. R.; Bates, S. E.; Price, D. K.; Rosing, D. R.; Cabell, C.; Sparreboom, A.; Figg, W. D.
  3. Clinical Cancer Research. 2011, Feb; 17(4): 937-946.
  1. 3.   Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
  2. Bates, S. E.; Zhan, Z. R.; Steadman, K.; Obrzut, T.; Luchenko, V.; Frye, R.; Robey, R. W.; Turner, M.; Gardner, E. R.; Figg, W. D.; Steinberg, S. M.; Ling, A.; Fojo, T.; To, K. W.; Piekarz, R. L.
  3. British Journal of Haematology. 2010, Jan; 148(2): 256-267.
  1. 4.   Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
  2. Piekarz, R. L.; Frye, R.; Turner, M.; Wright, J. J.; Allen, S. L.; Kirschbaum, M. H.; Zain, J.; Prince, H. M.; Leonard, J. P.; Geskin, L. J.; Reeder, C.; Joske, D.; Figg, W. D.; Gardner, E. R.; Steinberg, S. M.; Jaffe, E. S.; Stetler-Stevenson, M.
  3. Journal of Clinical Oncology. 2009 27(32): 5410-5417.
  1. 5.   Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
  2. Woo, S.; Gardner, E. R.; Chen, X. H.; Ockers, S. B.; Baum, C. E.; Sissung, T. M.; Price, D. K.; Frye, R.; Piekarz, R. L.; Bates, S. E.; Figg, W. D.
  3. Clinical Cancer Research. 2009 15(4): 1496-1503.
  1. 6.   Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detection
  2. Chen, X. H.; Gardner, E. R.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2008 865(1-2): 153-158.
  1. 7.   The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems
  2. Goldsmith, M. E.; Aguila, A.; Steadman, K.; Martinez, A.; Steinberg, S. M.; Alley, M. C.; Waud, W. R.; Bates, S. E.; Fojo, T.
  3. Molecular Cancer Therapeutics. 2007, Feb; 6(2): 496-505.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel